Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells

Molecular and Cellular Neuroscience

Volumn 22, Issue 4, 2003, Pages 430-440

  Leone, Dino P ^a   Genoud, Stéphane ^a   Atanasoski, Suzana ^a   Grausenburger, Reinhard ^a   Berger, Philipp ^a   Metzger, Daniel ^b   Macklin, Wendy B ^c   Chambon, Pierre ^b   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

^b l'alimentation et l'Environnement   (France)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; TAMOXIFEN;

ANIMAL CELL; ARTICLE; CELL LINE; CELL LINEAGE; CONTROLLED STUDY; CROSS BREEDING; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GLIA CELL; MOUSE; MUTAGENESIS; NONHUMAN; OLIGODENDROGLIA; PRECURSOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; REPORTER GENE; SCHWANN CELL; TRANSGENE;

EID: 0037396606     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00029-0     Document Type: Article

References (42)

1. Abel A., Bone L.J., Messing A., Scherer S.S., Fischbeck K.H. Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J. Neuropathol. Exp. Neurol. 58:1999;702-710.
2. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81:2001;871-927.
3. Brocard J., Warot X., Wendling O., Messaddeq N., Vonesch J.L., Chambon P., Metzger D. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc. Natl. Acad. Sci. USA. 94:1997;14559-14563.
4. Caley D.W., Maxwell D.S. An electron microscopic study of the neuroglia during postnatal development of the rat cerebrum. J. Comp. Neurol. 133:1968;45-70.
5. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8:1998;1323-1326.
6. Danielian P.S., White R., Hoare S.A., Fawell S.E., Parker M.G. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol. Endocrinol. 7:1993;232-240.
7. Doerflinger N.H., Macklin W.B., Popko B. Inducible site-specific recombination in myelinating cells. Genesis. 35:2003;63-72.
8. Feil R., Brocard J., Mascrez B., LeMeur M., Metzger D., Chambon P. Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. USA. 93:1996;10887-10890.
9. Feil R., Wagner J., Metzger D., Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun. 237:1997;752-757.
10. Foran D.R., Peterson A.C. Myelin acquisition in the central nervous system of the mouse revealed by an MBP-LacZ transgene. J. Neurosci. 12:1992;4890-4897.
11. Fuss B., Afshari F.S., Colello R.J., Macklin W.B. Normal CNS myelination in transgenic mice overexpressing MHC class I H-2L(d) in oligodendrocytes. Mol. Cell. Neurosci. 18:2001;221-234.
12. Hayashi S., McMahon A.P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre a tool for temporally regulated gene activation/inactivation in the mouse . Dev. Biol. 244:2002;305-318.
13. Hogan B., Beddington R., Costantini F., Lacy E. Manipulating the mouse embryo. 2nd Ed. 1994;Cold Spring Harbor Laboratory Press.
14. Hornyak T.A., Hayes D.J., Chiu L.Y., Ziff E.B. Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech. Dev. 101:2001;47-59.
15. Imai T., Jiang M., Chambon P., Metzger D. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc. Natl. Acad. Sci. USA. 98:2001;224-228.
16. Imai T., Jiang M., Kastner P., Chambon P., Metzger D. Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity. Proc. Natl. Acad. Sci. USA. 98:2001;4581-4586.
17. Indra A.K., Warot X., Brocard J., Bornert J.M., Xiao J.H., Chambon P., Metzger D. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases . Nucleic Acids Res. 27:1999;4324-4327.
18. Jessen K.R., Mirsky R. Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci. 22:1999;402-410.
19. Kahle P.J., Neumann M., Ozmen L., Muller V., Jacobsen H., Spooren W., Fuss B., Mallon B., Macklin W.B., Fujiwara H., Hasegawa M., Iwatsubo T., Kretzschmar H.A., Haass C. Hyperphosphorylation and insolubility of {alpha}-synuclein in transgenic mouse oligodendrocytes. EMBO Rep. 3:2002;583-588.
20. Kellendonk C., Tronche F., Casanova E., Anlag C., Opherk C., Schütz G. Inducible site-specific recombination in the brain. J. Mol. Biol. 285:1999;175-182.
21. Lewandoski M. Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2:2001;743-755.
22. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1995;1686-1690.
23. Lobsiger C.S., Taylor V., Suter U. The early life of a Schwann cell. Biol. Chem. 383:2002;245-253.
24. Mackenzie M.A., Jordan S.A., Budd P.S., Jackson I.J. Activation of the receptor tyrosine kinase kit is required for the proliferation of melanoblasts in the mouse embryo. Dev. Biol. 192:1997;99-107.
25. Mallon B.S., Shick H.E., Kidd G.J., Macklin W.B. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J. Neurosci. 22:2002;876-885.
26. Mansuy I.M., Suter U. Mouse genetics in cell biology. Exp. Physiol. 85:2000;661-679.
27. Messing A., Behringer R.R., Hammang J.P., Palmiter R.D., Brinster R.L., Lemke G. P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice. Neuron. 8:1992;507-520.
28. Messing A., Behringer R.R., Wrabetz L., Hammang J.P., Lemke G., Palmiter R.D., Brinster R.L. Hypomyelinating peripheral neuropathies and schwannomas in transgenic mice expressing SV40 T-antigen. J. Neurosci. 14:1994;3533-3539.
29. Metzger D., Chambon P. Site- and time-specific gene targeting in the mouse. Methods. 24:2001;71-80.
30. Metzger D., Clifford J., Chiba H., Chambon P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA. 92:1995;6991-6995.
31. Nagy A. Cre recombinase the universal reagent for genome tailoring . Genesis. 26:2000;99-109.
32. Schwenk F., Kuhn R., Angrand P.O., Rajewsky K., Stewart A.F. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 26:1998;1427-1432.
33. Skoff R.P., Toland D., Nast E. Pattern of myelination and distribution of neuroglial cells along the developing optic system of the rat and rabbit. J. Comp. Neurol. 191:1980;237-253.
34. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:1999;70-71.
35. Spassky N., Goujet-Zalc C., Parmantier E., Olivier C., Martinez S., Ivanova A., Ikenaka K., Macklin W., Cerruti I., Zalc B., Thomas J.L. Multiple restricted origin of oligodendrocytes. J. Neurosci. 18:1998;8331-8343.
36. Vallier L., Mancip J., Markossian S., Lukaszewicz A., Dehay C., Metzger D., Chambon P., Samarut J., Savatier P. An efficient system for conditional gene expression in embryonic stem cells and in their in vitro and in vivo differentiated derivatives. Proc. Natl. Acad. Sci. USA. 98:2001;2467-2472.
37. Vasioukhin V., Degenstein L., Wise B., Fuchs E. The magical touch genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin . Proc. Natl. Acad. Sci. USA. 96:1999;8551-8556.
38. Verity A.N., Campagnoni A.T. Regional expression of myelin protein genes in the developing mouse brain in situ hybridization studies . J. Neurosci. Res. 21:1988;238-248.
39. Vooijs M., Jonkers J., Berns A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. 2:2001;292-297.
40. Weber P., Metzger D., Chambon P. Temporally controlled targeted somatic mutagenesis in the mouse brain. Eur. J. Neurosci. 14:2001;1777-1783.
41. Wight P.A., Dobretsova A. The first intron of the myelin proteolipid protein gene confers cell type-specific expression by a transcriptional repression mechanism in non-expressing cell types. Gene. 201:1997;111-117.
42. Wight P.A., Duchala C.S., Readhead C., Macklin W.B. A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice. J. Cell. Biol. 123:1993;443-454.